Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001999288 | SCV002287439 | likely pathogenic | not provided | 2021-10-04 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with alanine at codon 423 of the ALPL protein (p.Val423Ala). The valine residue is weakly conserved and there is a small physicochemical difference between valine and alanine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with hypophosphatasia (PMID: 11438998, 20089612). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as TNSALP 1268T>C V406A. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available"). Experimental studies have shown that this missense change affects ALPL function (PMID: 11438998, 18422967). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV003471247 | SCV004193664 | pathogenic | Adult hypophosphatasia | 2023-10-24 | criteria provided, single submitter | clinical testing |